High glucose and interferon gamma synergistically stimulate MMP-1 expression in U937 macrophages by increasing transcription factor STAT1 activity

Atherosclerosis

Volumn 202, Issue 2, 2009, Pages 363-371

  Nareika, Alena ^b   Sundararaj, Kamala P ^b   Im, Yeong Bin ^b   Game, Bryan A ^a   Lopes Virella, Maria F ^a,b   Huang, Yan ^a,b  

^a RALPH H JOHNSON VA MEDICAL CENTER   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Atherosclerosis; Diabetes mellitus; Glucose; Inflammation; Interferon gamma; Matrix metalloproteinase

Indexed keywords

GAMMA INTERFERON; GELATINASE B; GLUCOSE; INTERLEUKIN 1BETA; INTERSTITIAL COLLAGENASE; LIPOPOLYSACCHARIDE; STAT1 PROTEIN;

ARTICLE; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CARDIOVASCULAR DISEASE; CELL CULTURE; CELL STRAIN U937; CONTROLLED STUDY; DIABETES MELLITUS; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME RELEASE; GENE EXPRESSION; HUMAN; HUMAN CELL; MACROPHAGE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION;

ATHEROSCLEROSIS; DIABETIC ANGIOPATHIES; DRUG SYNERGISM; GLUCOSE; HUMANS; HYPERGLYCEMIA; INTERFERON-GAMMA; INTERLEUKIN-1BETA; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MACROPHAGES; MATRIX METALLOPROTEINASE 1; MATRIX METALLOPROTEINASE 9; SIGNAL TRANSDUCTION; STAT1 TRANSCRIPTION FACTOR; TISSUE INHIBITOR OF METALLOPROTEINASE-1; TISSUE INHIBITOR OF METALLOPROTEINASE-2; U937 CELLS;

EID: 58549099467     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2008.05.043     Document Type: Article

References (22)

1. Pyorala K., Laakso M., and Unsitupa M. Diabetes and atherosclerosis: an epidemiologic view. Diabetes Metab Rev 3 (1987) 463-524
2. The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study Research Group. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med 353 (2005) 2643-2653
3. Esposito K., et al., Campanian Postprandial Hyperglycemia Study Group. Regression of carotid atherosclerosis by control of postprandial hyperglycemia in type 2 diabetes mellitus. Circulation 110 (2004) 214-219
4. Selvin E., Marinopoulos S., Berkenblit G., Rami T., Brancati F.L., Powe N.R., and Golden S.H. Meta-analysis: glycosylated hemoglobin and cardiovascular disease in diabetes mellitus. Ann Intern Med 141 (2004) 421-431
5. Yan S.F., Ramasamy R., Naka Y., and Schmidt A.M. Glycation, inflammation, and RAGE. Circ Res 93 (2003) 1159-1169
6. Ross R. Atherosclerosis-an inflammatory disease. New Engl J Med 340 (1999) 115-126
7. Libby P. Molecular bases of the acute coronary syndromes. Circulation 91 (1995) 2844-2850
8. Newby A.C. Dual role of matrix metalloproteinases (matrixins) in intimal thickening and atherosclerotic plaque rupture. Physiol Rev 85 (2005) 1-31
9. Amento E.P., Ehsani N., Palmer H., and Libby P. Cytokine and growth factors positively and negatively regulate interstitial collagen gene expression in human vascular smooth muscle cells. Arterioscler Thromb 11 (1991) 1223-1230
10. Zhou M., Zhang Y., Ardans J.A., and Wahl L.M. Interferon-γ differentially regulates monocyte matrix metalloproteinase-1 and -9 through tumor necrosis factor-α and caspase 8. J Biol Chem 278 (2003) 45406-45413
11. Sundstrom C., and Nilsson K. Establishment and characterization of a human histiocytic lymphoma cell line (U937). Int J Cancer 17 (1976) 565-577
12. Maldonado A., He L., Game B.A., Nareika A., Sanders J.J., London S.D., Lopes-Virella M.F., and Huang Y. Pre-exposure to high glucose augments lipopolysaccharide-stimulated matrix metalloproteinase-1 expression by human U937 histocytes. J Periodontal Res 39 (2004) 415-423
13. Nareika A., He L., Game B.A., Slate E.H., Sanders J.J., London S.D., Lopes-Virella M.F., and Huang Y. Sodium lactate increases LPS-stimulated MMP and cytokine expression in U937 histocytes by enhancing AP-1 and NFκB transcriptional activities. Am J Physiol (Endocrinol Metab) 289 (2005) E534-E542
14. Nareika A., Maldonado A., He L., Game B.A., Slate E.H., Sanders J.J., London S.D., Lopes-Virella M.F., and Huang Y. High glucose-boosted inflammatory responses to lipopolysaccharide are suppressed by statin. J Periodontal Res 42 (2006) 31-38
15. Danciger J.S., Lutz M., Hama S., Cruz D., Castrillo A., Lazaro J., Phillips R., Premack B., and Berliner J. Method for large scale isolation, culture and cryopreservation of human monocytes suitable for chemotaxis, cellular adhesion assays, macrophage and dendritic cell differentiation. J Immunol Methods 288 (2004) 123-134
16. Matrisian L.M. The matrix-degrading metalloproteinases. BioEssays 14 (1992) 455-463
17. Schroder K., Hertzog P.J., Ravasi T., and Hume D.A. Interferon-γ: an overview of signals, mechanisms and functions. J Leukocyte Biol 75 (2004) 163-189
18. Yamada H., Odonnell M.A., Matsumoto T., and Luo Y. Interferon-γ upregulates toll-like receptor 4 and cooperates with lipopolysaccharide to produce macrophage-derived chemokine and interferon-γ inducible protein-10 in human bladder cancer cell line RT4. J Urol 174 (2005) 1119-1123
19. Faber B.C.G., Heeneman S., Daemen M.J.A.P., and Cleutjens K.B.J.M. Genes potentially involved in plaque rupture. Curr Opin Lipidol 13 (2005) 545-552
20. Galis Z.S., and Khatri J.J. Matrix metalloproteinase in vascular remodeling and atherosclerosis. The good, the bad, and the ugly. Circ Res 90 (2002) 251-262
21. Jones C.B., Sane D.C., and Merrington D.M. Matrix metalloproteinases: a review of their structure and role in acute coronary syndromes. Cardiovasc Res 59 (2003) 812-823
22. Anderson F., Xu M., Game B.A., Atchley D., Lopes-Virella M.F., and Huang Y. IFN-γ pre-treatment augments immune complex-induced matrix metalloproteinase-1 expression in U937 histocytes. Clin Immunol 102 (2002) 200-207